A carregar...

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome

BACKGROUND: Aberrant promoter CpG island hypermethylation is associated with transcriptional silencing. Tumor suppressor genes are the key targets of hypermethylation in breast cancer and therefore may lead to malignancy by deregulation of cell growth and division. Our previous pilot study with pair...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Xu, Jia, Shetty, Priya B, Feng, Weiwei, Chenault, Carol, Bast, Robert C, Hilsenbeck, Susan G, Yu, Yinhua
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3476972/
https://ncbi.nlm.nih.gov/pubmed/22695491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!